GNI Group Ltd.

¥2,073As of Sun 8 Nov 2026, 12:00 UTC
TSE:2160Healthcare
Country Japan
PE (Fwd) •••
TSR 10Y CAGR 13.23%
Div yield —
ROE (10.30%)
Biotechnology
Beta (5Y) 1.20
PE TTM —
TSR TTM (14.90%)
Mkt cap ¥136.5B
ROIC (1.75%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
¥2,453
18.32%
(97.81%)
Hold 11|7|6|2|9
4Q25
1Q26
2Q26
3Q26
Earnings per share¥
27.31
29.88
29.08
31.03
(0.38%)
9.24%
8.91%
21.55%
Revenue¥B
6.750
7.018
6.901
7.081
1.20%
5.94%
1.76%
5.31%
Peers (US$866.6M)
Cap (US$)
PE
848.1M
—
864.4M
9.592x
Capital
TTM
5Y
10Y
Leveragex
3.960
0.252
0.215
EBIT/Intx
2.589
2.131
1.498
Own earn%
(297.96)
210.07
208.24
Sh yield%
25.01
54.18
54.23
Owners
Insiders/Inst%
2.11
74.59
Short interest%
1.33
SBC / revenue%
5.51
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
22
Op margin range%
2–7
$1 testx
—
Incr. ROIC%
4